Cyclerion Therapeutics Inc (NAS:CYCN)
$ 2.7 0.41 (17.98%) Market Cap: 6.75 Mil Enterprise Value: 1.05 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 47/100

Cyclerion Therapeutics Inc Corporate Overview Call Transcript

May 13, 2019 / 12:30PM GMT
Operator

Welcome to the Cyclerion Therapeutics Corporate Overview Conference Call.

(Operator Instructions)

At this time, I'll turn the call over to Brian Cali, Senior Vice President of Investor Relations and Corporate Communications. You may begin.

Brian Cali
Cyclerion Therapeutics - SVP IR, Corporate Communication

A press release was issued at 7 AM Eastern Time this morning that provided an overview of recent corporate progress and first quarter 2019 financial performance. We have also posted an updated corporate presentation on our web site.

Before we begin, let me review our safe harbor statement. Today's discussion contains forward looking statements. Such statements are based on current expectations and assumptions that are subject to risks and uncertainties and involve a number of risk factors that could cause actual results to differ materially from projected results -- in particular statements that include, but are not limited to the sufficiency of our cash and cash equivalents to fund operations; the anticipated timing of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot